Welcome to Venice
This Summit will bring together neurologists, movement disorder specialists, health professionals, residents, students and members of the International Parkinson and Movement Disorder Society.
They will discuss and celebrate therapeutic milestones in the treatment of Parkinson's disease, from Levodopa to surgical and device-aided therapies, into new biological and patient-centered approaches.
I’m happy to invite you to the first Summit on “Therapeutic Milestones in Parkinson’s Disease” organized by The International Parkinson and Movement Disorder Society-European Section (MDS-ES).
This is a buzzing time for researchers and people with Parkinson's disease. In the last decades we have achieved important milestones in understanding mechanisms of degeneration and contribution of genetics, testing innovative disease modification strategies, developing novel therapeutic targets and medications, optimizing dopaminergic drug delivery and improving neuromodulation techniques. Finally we have set new standards of care addressing the importance of a multidisciplinary team in disease management and are testing wearable sensors to develop digital endpoints facilitating remote monitoring and drug development.
The Scientific Program of the Summit will address those aspects providing a look into medicine of the future and the need to channel this knowledge into a personalized “patient-centric” approach.
Parkinson's has been the first neurodegenerative disease to see a symptomatic therapy and we hope it will be soon the first to see a cure.
We look forward to welcoming you to Venice in March of 2020 for the first MDS-ES Summit.
Chair, MDS-ES Summit Oversight Committee